Literature DB >> 11438463

Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa.

K Johnson1, S Hashimoto, M Lotz, K Pritzker, R Terkeltaub.   

Abstract

Two transglutaminases (TGases), Factor XIIIa and tissue TGase (tTGase), are expressed in temporal-spatial association with matrix calcification in growth plates. Meniscal and articular cartilage matrix calcification are prevalent in osteoarthritis (OA) and aging. Here, we demonstrated up-regulation of tTGase and Factor XIIIa in superficial and deep zones of knee OA articular cartilage and the central (chondrocytic) zone of OA menisci. Transforming growth factor-beta and interleukin (IL)-1beta induced Factor XIIIa and tTGase expression in cartilage and meniscal organ cultures. Thus, we studied TGase activity. Donor age-dependent, OA severity-related, and IL-1-induced increases in TGase activity were demonstrated in both knee menisci and cultured meniscal cells. Meniscal cell TGase activity was stimulated by nitric oxide donors and tumor necrosis factor-alpha, but transforming growth factor-beta did not stimulate TGase activity. The iNOS inhibitor N-monomethylarginine (NMMA) and an inhibitor of tumor necrosis factor receptor-associated factor (TRAF)2 and TRAF6 signaling (the zinc finger protein A20) suppressed IL-1 induction of TGase activity. Increased Factor XIIIa and tTGase activities, achieved via direct transfection of chondrocytic TC28 and meniscal cells, both induced matrix apatite deposition. Thus, Factor XIIIa and tTGase activities were increased in aging, degenerative cartilages and induced by IL-1. Because TGase activity promoted apatite deposition, our findings potentially implicate inflammation in the pathogenesis of cartilage matrix calcification.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438463      PMCID: PMC1850418          DOI: 10.1016/S0002-9440(10)61682-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules.

Authors:  C Vincenz; V M Dixit
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

2.  A20 zinc finger protein inhibits TNF and IL-1 signaling.

Authors:  M Jäättelä; H Mouritzen; F Elling; L Bastholm
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

Review 3.  Tissue transglutaminase and factor XIII in cartilage and bone remodeling.

Authors:  D Aeschlimann; D Mosher; M Paulsson
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

4.  A histological study of calcium pyrophosphate dihydrate crystal-deposition disease.

Authors:  K Ishikawa; I Masuda; T Ohira; M Yokoyama
Journal:  J Bone Joint Surg Am       Date:  1989-07       Impact factor: 5.284

5.  Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes.

Authors:  Y Geng; J Valbracht; M Lotz
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

6.  Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements.

Authors:  A Krikos; C D Laherty; V M Dixit
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

7.  Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate.

Authors:  A M Reginato; R V Iozzo; S A Jimenez
Journal:  Arthritis Rheum       Date:  1994-09

8.  A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets.

Authors:  S T Grey; M B Arvelo; W Hasenkamp; F H Bach; C Ferran
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

9.  Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes.

Authors:  D Aeschlimann; A Wetterwald; H Fleisch; M Paulsson
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

10.  Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate.

Authors:  D Aeschlimann; O Kaupp; M Paulsson
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

View more
  40 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

Review 2.  Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint.

Authors:  Niamh Fahy; Eric Farrell; Thomas Ritter; Aideen E Ryan; J Mary Murphy
Journal:  Tissue Eng Part B Rev       Date:  2014-08-04       Impact factor: 6.389

Review 3.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

4.  Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.

Authors:  Kristen A Johnson; Monika Polewski; Robert A Terkeltaub
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

5.  Regulation of gene expression by PI3K in mouse growth plate chondrocytes.

Authors:  Veronica Ulici; Claudine G James; Katie D Hoenselaar; Frank Beier
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

6.  Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.

Authors:  Jin Wang; Yannan Ouyang; Yigit Guner; Henri R Ford; Anatoly V Grishin
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

Review 7.  Calcium pyrophosphate dihydrate and basic calcium phosphate crystal-induced arthropathies: update on pathogenesis, clinical features, and therapy.

Authors:  Hang-Korng Ea; Frédéric Lioté
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

Review 8.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

Review 9.  Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinician.

Authors:  Salih Pay; Robert Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

10.  Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.

Authors:  Denise L Cecil; Robert Terkeltaub
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.